Investment
Features
FeesSafety
Academy
More
Pluang+

Compare VanEck Video Gaming and eSports ETF (ESPO) vs Eli Lilly And Co (LLY) Price & Performance

VanEck Video Gaming and eSports ETFTrade
Eli Lilly And CoTrade

Price performance (Past 24H)

Key statistics

VanEck Video Gaming and eSports ETF vs Eli Lilly And Co — how do they compare? VanEck Video Gaming and eSports ETF trades at $91.98, while Eli Lilly And Co trades at $1,170.46 (market cap $1.03T). The key difference: Eli Lilly And Co pays a 0.6% dividend while VanEck Video Gaming and eSports ETF pays none. Which is the better fit depends on your goals.

ESPOLLY
Sector
Sector/ThematicHealth
52-Week High
$122.30$1.24K
52-Week Low
$85.25$625.65
Market Cap
$1.03T
Enterprise Value
$1.07T
Dividend Yield
0.6%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

VanEck Video Gaming and eSports ETF

ESPO trades at $91.98, up 0.47% today, with technical indicators showing a bullish trend supported by moving averages. The ETF benefits from positive sentiment around AI-driven profit potential in the gaming industry. Recent institutional buying by Assetmark Inc. highlights growing confidence in the digital entertainment sector's growth prospects.

The outlook remains positive given AI's potential to boost gaming industry profits by $22 billion, though risks include sector competition and market volatility. Current technical strength near key support levels suggests potential for continued upward momentum if broader market conditions remain favorable.

Eli Lilly And Co

Eli Lilly (LLY) trades at $1,176.75, up 1.95% on the day, with strong fundamentals including a 31.66% net margin and consistent earnings beats. The stock shows a bearish technical signal near resistance at $1,177, while recent news highlights the $2.8 billion acquisition of AtaiBeckley to expand its mental health pipeline. Operating cash flow surged to $16.81 billion in 2025, supporting growth initiatives in obesity and Alzheimer's treatments.

Outlook remains positive with a $1.38K analyst price target and 73% buy ratings, but risks include competitive pressure in obesity drugs and high valuation multiples. Revenue growth of 65% in 2025 underscores momentum, though debt levels and acquisition integration pose challenges for sustained outperformance.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About VanEck Video Gaming and eSports ETF

ESPO is a thematic ETF that invests in the global video gaming and eSports industry. It provides exposure to companies involved in game development, hardware, and streaming, including major firms like Tencent, Nintendo, and Electronic Arts.

Read more on ESPO

About Eli Lilly And Co

Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer

Read more on LLY